Full Text View
Tabular View
No Study Results Posted
Related Studies
Phase II Study of Amithiozone (Thiacetazone) for Patients With Mycobacterium Avium Complex Pulmonary Disease
This study is ongoing, but not recruiting participants.
Study NCT00004689   Information provided by FDA Office of Orphan Products Development
First Received: February 24, 2000   Last Updated: June 23, 2005   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Additional conditions recognized in this trial
Communicable Diseases
Infection
Mycobacterium avium-intracellulare Infection
Mycobacterium Infections
More general conditions related to this trial
Actinomycetales Infections
Bacterial Infections
Gram-Positive Bacterial Infections
Mycobacterium Infections, Atypical
Interventions listed in this trial
amithiozone
clarithromycin
ethambutol
rifampin
streptomycin
Additional drug interventions recognized in this trial
Thioacetazone
More general drug interventions related to this trial
Anti-Bacterial Agents
Anti-Infective Agents
Antitubercular Agents
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Protein Synthesis Inhibitors
Therapeutic Uses
Sponsors listed in this trial
FDA Office of Orphan Products Development
National Jewish Health


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services